POLYCYSTIC OVARY SYNDROME (PCOS) TREATMENT MARKET ANALYSIS

Polycystic Ovary Syndrome (PCOS) Treatment Market, By Drug Class (Oral contraceptives, Insulin Sensitizing Agents, Anti-Depressants, Ornithine Decarboxylase Inhibitors, Aromatase Inhibitors & SERMs and Diuretics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Apr 2023
Code : CMI1589
Pages :177
Formats :
Excel and PDF
Industry : Pharmaceutical

Polycystic Ovary Syndrome (PCOS) Treatment MarketSize and Trends

The global polycystic ovary syndrome (PCOS) treatment market is estimated to be valued at US$ 1,086.6 million in 2023 and is expected to exhibit a CAGR of 4.86% during the forecast period (2023-2030).

Figure 2. Global Polycystic Ovary Syndrome (PCOS) Treatment Market Value (US$ Million), by Region, 2023

Based on Region, the polycystic ovary syndrome (PCOS) treatment market is segmented into regions, which include North America, Latin America, Europe, Asia Pacific, Middle East, and Africa, out of which the North America is expected to dominate the market over the forecast period and this is attributed to increase in the launch of the drugs by the key market players.